Abstract: |
Background. The purpose of this study was to investigate the extent of pre-exerciseparticipation (“preparticipation”) health screening in a heterogeneous cohort of adult cancer patients. Methods. Patients (n = 413) with histologically confirmed solid or hematologic malignancy were categorized into preparticipation health screening risk stratification based on American College Sports Medicine (ACSM) recommendations. Risk of an exercise-related event was evaluated during a symptom-limited cardiopulmonary exercise test (CPET) with 12-lead electrocardiography (ECG). Results. Participant risk was categorized as low risk (n = 59, 14%), moderate risk (n = 217, 53%), and high risk (n = 137, 33%). Mean peakoxygen consumption was 21.7 6 6.7 mL/kg21 per minute21 or 19.5 6 21.7% below age- and sex-predicted sedentary values. No major serious adverse events or fatal events were observed during CPET procedures. A total of 31 positive ECG tests were observed, for an event rate of 8%. ACSM risk stratification did not predict the risk of a positive test. Age, statin use, antiplatelet therapy use, cardiovascular disease, prior treatment with anthracycline or radiation therapy, and being sedentary were predictors of a positive test (all p < .10). Conclusion. The patient risk-stratification profile strongly suggests that the use of formalized preparticipation health screening is required in all oncology scenarios; however, riskof an exercise-induced event is low, suggesting that the use of exercisetestingis not required for pre-exercise clearance in the majority of patients. |